122 related articles for article (PubMed ID: 27362901)
21. Pelvic recurrence of an ovarian seromucinous borderline tumor detected by vaginal cytology: A case report and review of the literature.
Hayashi H; Taniguchi S; Kurihara S; Hachisuga K; Fukuda S; Inada C; Shimao Y; Marutsuka K; Shimamoto T
Diagn Cytopathol; 2016 Nov; 44(11):912-916. PubMed ID: 27381491
[TBL] [Abstract][Full Text] [Related]
22. Ovarian Seromucinous Tumors: Pathogenesis, Morphologic Spectrum, and Clinical Issues.
Nagamine M; Mikami Y
Diagnostics (Basel); 2020 Jan; 10(2):. PubMed ID: 32023964
[TBL] [Abstract][Full Text] [Related]
23. Seromucinous borderline tumor of the testis-A case report.
Scholz B; Beckert M; Mordstein V; Hohmann N; Walther R; Papadopoulos T
Hum Pathol; 2017 Feb; 60():188-191. PubMed ID: 27597522
[TBL] [Abstract][Full Text] [Related]
24. Ovarian mucinous and seromucinous neoplasms: problematic aspects and modern diagnostic approach.
Talia KL; Parra-Herran C; McCluggage WG
Histopathology; 2022 Jan; 80(2):255-278. PubMed ID: 33963606
[TBL] [Abstract][Full Text] [Related]
25. Mucinous tumors of the ovary: a review.
Hart WR
Int J Gynecol Pathol; 2005 Jan; 24(1):4-25. PubMed ID: 15626914
[TBL] [Abstract][Full Text] [Related]
26. Prognostic similarity between ovarian mucinous carcinoma with expansile invasion and ovarian mucinous borderline tumor: A retrospective analysis.
Hada T; Miyamoto M; Ishibashi H; Matsuura H; Sakamoto T; Kakimoto S; Iwahashi H; Suzuki R; Sato K; Tsuda H; Takano M
Medicine (Baltimore); 2021 Aug; 100(32):e26895. PubMed ID: 34397915
[TBL] [Abstract][Full Text] [Related]
27. Ovarian Seromucinous Borderline Tumors Are Histologically Different from Mucinous Borderline Tumors.
Hada T; Miyamoto M; Ishibashi H; Kawauchi H; Soyama H; Matsuura H; Sakamoto T; Kakimoto S; Aoyama T; Iwahashi H; Suzuki R; Tsuda H; Takano M
In Vivo; 2020; 34(3):1341-1346. PubMed ID: 32354928
[TBL] [Abstract][Full Text] [Related]
28. Borderline mucinous endocervical tumor as a link between the endometriotic cyst and ovarian primary squamous cell carcinoma.
Zannoni GF; Vellone VG; Chiarello G
Int J Gynecol Pathol; 2011 Jul; 30(4):396-7. PubMed ID: 21623198
[No Abstract] [Full Text] [Related]
29. Ovarian epithelial tumours of borderline malignancy: pathological features and current status.
Br J Obstet Gynaecol; 1983 Aug; 90(8):743-50. PubMed ID: 6309211
[No Abstract] [Full Text] [Related]
30. [Immunohistological demonstration of peptide hormones and serotonin in ovarian mucinous and endometrioid tumors with argyrophil cells].
Inoue Y; Ueda G; Yamasaki M; Inoue M; Tanaka Y; Nishino T; Saito J; Abe Y; Tanizawa O
Nihon Sanka Fujinka Gakkai Zasshi; 1986 Mar; 38(3):361-5. PubMed ID: 2871119
[TBL] [Abstract][Full Text] [Related]
31. Expression of REG4 in ovarian mucinous tumors.
Huang Q; Chen X; Lu W; Lai M; Lu B
Appl Immunohistochem Mol Morphol; 2014 Apr; 22(4):295-301. PubMed ID: 23958547
[TBL] [Abstract][Full Text] [Related]
32. Abdominal wall implantation of an endocervical-like mucinous borderline tumor.
Measham C; Rutgers JL
Mod Pathol; 1996 Apr; 9(4):381-5. PubMed ID: 8729976
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of Endometriosis in Malignant Epithelial Ovarian Tumor.
Akbarzadeh-Jahromi M; Shekarkhar G; Sari Aslani F; Azarpira N; Heidari Esfahani M; Momtahan M
Arch Iran Med; 2015 Dec; 18(12):844-8. PubMed ID: 26621017
[TBL] [Abstract][Full Text] [Related]
34. Newly Categorized Seromucinous Tumor of the Ovary: Magnetic Resonance Imaging Findings.
Han JW; Kim KA; Chang HY; Kim JW; Park YS; Lee J; Choi JW; Lee CH; Park CM
J Comput Assist Tomogr; 2019; 43(1):119-127. PubMed ID: 30052618
[TBL] [Abstract][Full Text] [Related]
35. Prognostic analysis of ovarian cancer associated with endometriosis.
Kumar S; Munkarah A; Arabi H; Bandyopadhyay S; Semaan A; Hayek K; Garg G; Morris R; Ali-Fehmi R
Am J Obstet Gynecol; 2011 Jan; 204(1):63.e1-7. PubMed ID: 21074136
[TBL] [Abstract][Full Text] [Related]
36. Pelvic seromucinous borderline tumor 26 years after ovarian seromucinous borderline tumor managed with post-treatment estrogen replacement therapy.
Uehara T; Yoshida H; Kato T
Gynecol Oncol Rep; 2021 Feb; 35():100692. PubMed ID: 33490352
[TBL] [Abstract][Full Text] [Related]
37. Clinical characteristics and prognosis of mucinous tumors of the ovary.
Kikkawa F; Nawa A; Kajiyama H; Shibata K; Ino K; Nomura S
Gynecol Oncol; 2006 Oct; 103(1):171-5. PubMed ID: 16546243
[TBL] [Abstract][Full Text] [Related]
38. Ovarian intestinal type mucinous borderline tumors: are we ready for a nomenclature change?
Chiesa AG; Deavers MT; Veras E; Silva EG; Gershenson D; Malpica A
Int J Gynecol Pathol; 2010 Mar; 29(2):108-12. PubMed ID: 20173495
[TBL] [Abstract][Full Text] [Related]
39. Intestinal-type mucinous ovarian carcinoma arising from a seromucinous precursor lesion.
Santoro A; D'Alessandris N; Travaglino A; Arciuolo D; Inzani F; Angelico G; Scaglione G; Valente M; Raffone A; Zannoni GF
Eur Rev Med Pharmacol Sci; 2022 Feb; 26(4):1263-1267. PubMed ID: 35253183
[TBL] [Abstract][Full Text] [Related]
40. "Piling up" clear cells in müllerian-type mucinous and mixed cell-type borderline tumor do not represent concomitant clear cell neoplasms.
Ohishi Y; Kurihara S; Aman M; Takeuchi T; Imamura H; Kaku T; Kobayashi H; Wake N; Oda Y
Hum Pathol; 2012 Oct; 43(10):1618-26. PubMed ID: 22436624
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]